NYSE: MED

Medifast Inc Stock Forecast, Predictions & Price Target

The consensus among 1 Wall Street analyst covering (NYSE: MED) stock is to Hold MED stock.

Out of 1 analyst, 0 (0%) are recommending MED as a Strong Buy, 0 (0%) are recommending MED as a Buy, 1 (100%) are recommending MED as a Hold, 0 (0%) are recommending MED as a Sell, and 0 (0%) are recommending MED as a Strong Sell.

If you're new to stock investing, here's how to buy Medifast stock.

(NYSE: MED) Medifast's forecast annual revenue growth rate of 4.42% is not forecast to beat the US Personal Services industry's average forecast revenue growth rate of 6.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.3%.

Medifast's revenue in 2024 is $1,072,054,000.On average, 1 Wall Street analysts forecast MED's revenue for 2024 to be $10,953,886,433, with the lowest MED revenue forecast at $10,953,886,433, and the highest MED revenue forecast at $10,953,886,433. On average, 1 Wall Street analysts forecast MED's revenue for 2025 to be $12,607,401,930, with the lowest MED revenue forecast at $12,607,401,930, and the highest MED revenue forecast at $12,607,401,930.

In 2026, MED is forecast to generate $14,645,749,843 in revenue, with the lowest revenue forecast at $14,645,749,843 and the highest revenue forecast at $14,645,749,843.

According to 1 Wall Street analyst that have issued a 1 year MED price target, the average MED price target is $40.00, with the highest MED stock price forecast at $40.00 and the lowest MED stock price forecast at $40.00.

The Wall Street analyst predicted that Medifast's share price could reach $40.00 by Feb 21, 2025. The average Medifast stock price prediction forecasts a potential upside of 19.69% from the current MED share price of $33.42.

(NYSE: MED) forecast ROE is N/A, which is considered weak.